Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 378

1.

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2018 Jul 9. doi: 10.1007/s40268-018-0239-7. [Epub ahead of print]

PMID:
29987670
2.

Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, Ramsey D, Milev E, Civitello M, Pane M, Pera MC, Scoto M, Day JW, Tennekoon G, Finkel RS, Darras BT, Muntoni F, De Vivo DC, Mercuri E.

PLoS One. 2018 Jun 26;13(6):e0199657. doi: 10.1371/journal.pone.0199657. eCollection 2018.

3.

Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.

Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, Ramsey D, Muni Lofra R, Coratti G, Fanelli L, De Sanctis R, Forcina N, Chiriboga C, Darras BT, Tennekoon GI, Scoto M, Day JW, Finkel R, Muntoni F, Mercuri E, De Vivo DC.

Pediatr Phys Ther. 2018 Jul;30(3):209-215. doi: 10.1097/PEP.0000000000000515.

PMID:
29924070
4.

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR study.

Capdevila J, Teulé A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, García-Carbonero R, Dotor E, Matos I, Custodio A, Casanovas O, Salazar R; EVERLAR study investigators.

Oncologist. 2018 May 23. pii: theoncologist.2017-0622. doi: 10.1634/theoncologist.2017-0622. [Epub ahead of print]

PMID:
29794066
5.

Treatment of winery wastewater by anodic oxidation using BDD electrode.

Candia-Onfray C, Espinoza N, Sabino da Silva EB, Toledo-Neira C, Espinoza LC, Santander R, García V, Salazar R.

Chemosphere. 2018 Sep;206:709-717. doi: 10.1016/j.chemosphere.2018.04.175. Epub 2018 May 4.

PMID:
29783056
6.

Degradation of ampicillin antibiotic by electrochemical processes: evaluation of antimicrobial activity of treated water.

Vidal J, Huiliñir C, Santander R, Silva-Agredo J, Torres-Palma RA, Salazar R.

Environ Sci Pollut Res Int. 2018 May 17. doi: 10.1007/s11356-018-2234-5. [Epub ahead of print]

PMID:
29770941
7.

Depolymerization of Trityl End-Capped Poly(Ethyl Glyoxylate): Potential Applications in Smart Packaging.

Fan B, Salazar R, Gillies ER.

Macromol Rapid Commun. 2018 Jun;39(11):e1800173. doi: 10.1002/marc.201800173. Epub 2018 Apr 26.

PMID:
29700924
8.

RET-fusions: a novel paradigm in colorectal cancer.

Santos C, Sanz-Pamplona R, Salazar R.

Ann Oncol. 2018 Jun 1;29(6):1340-1343. doi: 10.1093/annonc/mdy132. No abstract available.

PMID:
29648570
9.

Effective removal of the antibiotic Nafcillin from water by combining the Photoelectro-Fenton process and Anaerobic Biological Digestion.

Vidal J, Huiliñir C, Santander R, Silva-Agredo J, Torres-Palma RA, Salazar R.

Sci Total Environ. 2018 May 15;624:1095-1105. doi: 10.1016/j.scitotenv.2017.12.159. Epub 2017 Dec 27.

PMID:
29625524
10.

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2018 Jun;18(2):119-128. doi: 10.1007/s40268-018-0231-2. Erratum in: Drugs R D. 2018 Jul 9;:.

11.

Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease.

Salazar R.

Clin Neurol Neurosurg. 2018 May;168:72-76. doi: 10.1016/j.clineuro.2018.02.043. Epub 2018 Mar 5.

PMID:
29525731
12.

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.

Montagut C, Argilés G, Ciardiello F, Poulsen TT, Dienstmann R, Kragh M, Kopetz S, Lindsted T, Ding C, Vidal J, Clausell-Tormos J, Siravegna G, Sánchez-Martín FJ, Koefoed K, Pedersen MW, Grandal MM, Dvorkin M, Wyrwicz L, Rovira A, Cubillo A, Salazar R, Desseigne F, Nadal C, Albanell J, Zagonel V, Siena S, Fumi G, Rospo G, Nadler P, Horak ID, Bardelli A, Tabernero J.

JAMA Oncol. 2018 Apr 12;4(4):e175245. doi: 10.1001/jamaoncol.2017.5245. Epub 2018 Apr 12.

13.

Electrochemical degradation of industrial textile dye disperse yellow 3: Role of electrocatalytic material and experimental conditions on the catalytic production of oxidants and oxidation pathway.

Salazar R, Ureta-Zañartu MS, González-Vargas C, Brito CDN, Martinez-Huitle CA.

Chemosphere. 2018 May;198:21-29. doi: 10.1016/j.chemosphere.2017.12.092. Epub 2017 Dec 28.

PMID:
29421732
14.

Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime?

Vivancos A, Élez E, Salazar R.

Ann Oncol. 2018 Mar 1;29(3):532-534. doi: 10.1093/annonc/mdy043. No abstract available.

PMID:
29401228
15.

Trypanosoma cruzi Infection Does Not Decrease Survival or Reproduction of the Common Bed Bug, Cimex lectularius.

Peterson JK, Salazar R, Castillo-Neyra R, Borrini-Mayori K, Condori C, Bartow-McKenney C, Tracy D, Náquira C, Levy MZ.

Am J Trop Med Hyg. 2018 Mar;98(3):724-734. doi: 10.4269/ajtmh.17-0593. Epub 2018 Jan 18.

PMID:
29363461
16.

Exact mean-energy expansion of Ginibre's gas for coupling constants Γ=2×(oddinteger).

Salazar R, Téllez G.

Phys Rev E. 2017 Dec;96(6-1):062145. doi: 10.1103/PhysRevE.96.062145. Epub 2017 Dec 26.

PMID:
29347313
17.

Search for Neutrinoless Quadruple-β Decay of ^{150}Nd with the NEMO-3 Detector.

Arnold R, Augier C, Barabash AS, Basharina-Freshville A, Blondel S, Blot S, Bongrand M, Boursette D, Brudanin V, Busto J, Caffrey AJ, Calvez S, Cascella M, Cerna C, Cesar JP, Chapon A, Chauveau E, Chopra A, Dawson L, Duchesneau D, Durand D, Egorov V, Eurin G, Evans JJ, Fajt L, Filosofov D, Flack R, Garrido X, Gómez H, Guillon B, Guzowski P, Hodák R, Huber A, Hubert P, Hugon C, Jullian S, Klimenko A, Kochetov O, Konovalov SI, Kovalenko V, Lalanne D, Lang K, Lemière Y, Le Noblet T, Liptak Z, Liu XR, Loaiza P, Lutter G, Macko M, Macolino C, Mamedov F, Marquet C, Mauger F, Morgan B, Mott J, Nemchenok I, Nomachi M, Nova F, Nowacki F, Ohsumi H, Patrick C, Pahlka RB, Perrot F, Piquemal F, Povinec P, Přidal P, Ramachers YA, Remoto A, Reyss JL, Riddle CL, Rukhadze E, Saakyan R, Salazar R, Sarazin X, Shitov Y, Simard L, Šimkovic F, Smetana A, Smolek K, Smolnikov A, Söldner-Rembold S, Soulé B, Štefánik D, Štekl I, Suhonen J, Sutton CS, Szklarz G, Thomas J, Timkin V, Torre S, Tretyak VI, Tretyak VI, Umatov VI, Vanushin I, Vilela C, Vorobel V, Waters D, Xie F, Žukauskas A; NEMO-3 Collaboration.

Phys Rev Lett. 2017 Jul 28;119(4):041801. doi: 10.1103/PhysRevLett.119.041801. Epub 2017 Jul 24.

PMID:
29341770
18.

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.

Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC.

Oncologist. 2017 Dec 14. pii: theoncologist.2017-0144. doi: 10.1634/theoncologist.2017-0144. [Epub ahead of print]

PMID:
29242283
19.

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.

Taieb J, Kourie HR, Emile JF, Le Malicot K, Balogoun R, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Mulot C, Bouché O, Aparicio T, Michel P, Thaler J, Bridgewater J, Van Cutsem E, Perkins G, Lepage C, Salazar R, Laurent-Puig P; Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Investigators.

JAMA Oncol. 2018 Jul 12;4(7):e173695. doi: 10.1001/jamaoncol.2017.3695. Epub 2018 Jul 12.

PMID:
29167892
20.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Abad A, Martínez-Balibrea E, Viéitez JM, Alonso-Orduña V, García Alfonso P, Manzano JL, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E.

Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.

PMID:
29145602
21.

Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.

Antonio M, Carmona-Bayonas A, Saldaña J, Navarro V, Tebé C, Salazar R, Borràs JM.

Clin Colorectal Cancer. 2018 Mar;17(1):e59-e68. doi: 10.1016/j.clcc.2017.09.003. Epub 2017 Sep 28.

PMID:
29054805
22.

DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time?

Páez D, Salazar R, Tabernero J.

Ann Oncol. 2017 Dec 1;28(12):2913-2914. doi: 10.1093/annonc/mdx632. No abstract available.

PMID:
29045550
23.

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.

Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
28988646
24.

Physicochemical properties of nixtamalized black bean (Phaseolus vulgaris L.) flours.

Santiago-Ramos D, Figueroa-Cárdenas JD, Véles-Medina JJ, Salazar R.

Food Chem. 2018 Feb 1;240:456-462. doi: 10.1016/j.foodchem.2017.07.156. Epub 2017 Jul 29.

PMID:
28946298
25.

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.

Garcia-Carbonero R, Salazar R, Duran I, Osman-Garcia I, Paz-Ares L, Bozada JM, Boni V, Blanc C, Seymour L, Beadle J, Alvis S, Champion B, Calvo E, Fisher K.

J Immunother Cancer. 2017 Sep 19;5(1):71. doi: 10.1186/s40425-017-0277-7.

26.

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.

Gonçalves-Ribeiro S, Sanz-Pamplona R, Vidal A, Sanjuan X, Guillen Díaz-Maroto N, Soriano A, Guardiola J, Albert N, Martínez-Villacampa M, López I, Santos C, Serra-Musach J, Salazar R, Capellà G, Villanueva A, Molleví DG.

Ann Oncol. 2017 Sep 1;28(9):2160-2168. doi: 10.1093/annonc/mdx293.

PMID:
28911071
27.

[Breastfeeding, gross motor development and obesity, is there any causal association?]

Weisstaub N G, Schonhaut B L, Salazar R G.

Rev Chil Pediatr. 2017;88(4):451-457. doi: 10.4067/S0370-41062017000400002. Review. Spanish.

28.

Sorting Overlapping Spike Waveforms from Electrode and Tetrode Recordings.

Mokri Y, Salazar RF, Goodell B, Baker J, Gray CM, Yen SC.

Front Neuroinform. 2017 Aug 17;11:53. doi: 10.3389/fninf.2017.00053. eCollection 2017.

29.

Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study.

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A.

Drugs R D. 2017 Sep;17(3):419-425. doi: 10.1007/s40268-017-0198-4.

30.

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Alonso MH, Aussó S, Lopez-Doriga A, Cordero D, Guinó E, Solé X, Barenys M, de Oca J, Capella G, Salazar R, Sanz-Pamplona R, Moreno V.

Br J Cancer. 2017 Jul 25;117(3):421-431. doi: 10.1038/bjc.2017.208. Epub 2017 Jul 6.

PMID:
28683472
31.

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.

Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R.

Mol Cancer Ther. 2017 Sep;16(9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. Epub 2017 Jun 16.

PMID:
28626084
32.

Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease.

Lachner C, Armstrong MJ, Gruber-Baldini AL, Rezvani Z, Reich SG, Fishman PS, Salazar R, Shulman LM.

J Geriatr Psychiatry Neurol. 2017 Jul;30(4):191-195. doi: 10.1177/0891988717710335. Epub 2017 May 24.

PMID:
28535723
33.

Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?

Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM.

Oncologist. 2017 Aug;22(8):934-943. doi: 10.1634/theoncologist.2016-0462. Epub 2017 May 9.

PMID:
28487465
34.

Dual tasking in Parkinson's disease: Cognitive consequences while walking.

Salazar RD, Ren X, Ellis TD, Toraif N, Barthelemy OJ, Neargarder S, Cronin-Golomb A.

Neuropsychology. 2017 Sep;31(6):613-623. doi: 10.1037/neu0000331. Epub 2017 Apr 17.

PMID:
28414497
35.

Experimental and Theoretical Reduction Potentials of Some Biologically Active ortho-Carbonyl para-Quinones.

Martínez-Cifuentes M, Salazar R, Ramírez-Rodríguez O, Weiss-López B, Araya-Maturana R.

Molecules. 2017 Apr 4;22(4). pii: E577. doi: 10.3390/molecules22040577.

36.

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.

Grasselli J, Elez E, Caratù G, Matito J, Santos C, Macarulla T, Vidal J, Garcia M, Viéitez JM, Paéz D, Falcó E, Lopez Lopez C, Aranda E, Jones F, Sikri V, Nuciforo P, Fasani R, Tabernero J, Montagut C, Azuara D, Dienstmann R, Salazar R, Vivancos A.

Ann Oncol. 2017 Jun 1;28(6):1294-1301. doi: 10.1093/annonc/mdx112.

37.

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.

Kulke MH, Ruszniewski P, Van Cutsem E, Lombard-Bohas C, Valle JW, De Herder WW, Pavel M, Degtyarev E, Brase JC, Bubuteishvili-Pacaud L, Voi M, Salazar R, Borbath I, Fazio N, Smith D, Capdevila J, Riechelmann RP, Yao JC.

Ann Oncol. 2017 Jun 1;28(6):1309-1315. doi: 10.1093/annonc/mdx078.

PMID:
28327907
38.

The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Salazar RD, Le AM, Neargarder S, Cronin-Golomb A.

Parkinsonism Relat Disord. 2017 May;38:26-30. doi: 10.1016/j.parkreldis.2017.01.011. Epub 2017 Jan 24.

39.

The Parkinson's Active Living (PAL) Program.

Butterfield LC, Cimino CR, Salazar R, Sanchez-Ramos J, Bowers D, Okun MS.

J Geriatr Psychiatry Neurol. 2017 Jan;30(1):11-25. doi: 10.1177/0891988716673467. Epub 2016 Oct 17.

PMID:
28248557
40.

Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy.

Pera MC, Coratti G, Forcina N, Mazzone ES, Scoto M, Montes J, Pasternak A, Mayhew A, Messina S, Sframeli M, Main M, Lofra RM, Duong T, Ramsey D, Dunaway S, Salazar R, Fanelli L, Civitello M, de Sanctis R, Antonaci L, Lapenta L, Lucibello S, Pane M, Day J, Darras BT, De Vivo DC, Muntoni F, Finkel R, Mercuri E.

BMC Neurol. 2017 Feb 23;17(1):39. doi: 10.1186/s12883-017-0790-9.

41.

Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.

Ramsey D, Scoto M, Mayhew A, Main M, Mazzone ES, Montes J, de Sanctis R, Dunaway Young S, Salazar R, Glanzman AM, Pasternak A, Quigley J, Mirek E, Duong T, Gee R, Civitello M, Tennekoon G, Pane M, Pera MC, Bushby K, Day J, Darras BT, De Vivo D, Finkel R, Mercuri E, Muntoni F.

PLoS One. 2017 Feb 21;12(2):e0172346. doi: 10.1371/journal.pone.0172346. eCollection 2017.

42.

Reply to: Spontaneous Intracranial Hypotension and its Association with Movement Disorders?

Salazar R.

Tremor Other Hyperkinet Mov (N Y). 2016 Nov 14;6:432. eCollection 2016.

43.

Gate-Controlled WSe2 Transistors Using a Buried Triple-Gate Structure.

Müller MR, Salazar R, Fathipour S, Xu H, Kallis K, Künzelmann U, Seabaugh A, Appenzeller J, Knoch J.

Nanoscale Res Lett. 2016 Dec;11(1):512. Epub 2016 Nov 22.

44.

Gait assessment with solesound instrumented footwear in spinal muscular atrophy.

Montes J, Zanotto D, Dunaway Young S, Salazar R, De Vivo DC, Agrawal S.

Muscle Nerve. 2017 Aug;56(2):230-236. doi: 10.1002/mus.25484. Epub 2017 Feb 15.

PMID:
27863443
45.

Developmental milestones in type I spinal muscular atrophy.

De Sanctis R, Coratti G, Pasternak A, Montes J, Pane M, Mazzone ES, Young SD, Salazar R, Quigley J, Pera MC, Antonaci L, Lapenta L, Glanzman AM, Tiziano D, Muntoni F, Darras BT, De Vivo DC, Finkel R, Mercuri E.

Neuromuscul Disord. 2016 Nov;26(11):754-759. doi: 10.1016/j.nmd.2016.10.002. Epub 2016 Oct 5.

46.

Temporal and spatial gait parameters in children with Cri du Chat Syndrome under single and dual task conditions.

Abbruzzese LD, Salazar R, Aubuchon M, Rao AK.

Gait Posture. 2016 Oct;50:47-52. doi: 10.1016/j.gaitpost.2016.08.006. Epub 2016 Aug 5.

PMID:
27569649
47.

Six-minute walk test is reliable and valid in spinal muscular atrophy.

Dunaway Young S, Montes J, Kramer SS, Marra J, Salazar R, Cruz R, Chiriboga CA, Garber CE, De Vivo DC.

Muscle Nerve. 2016 Nov;54(5):836-842. doi: 10.1002/mus.25120. Epub 2016 May 13.

PMID:
27015431
48.

Revised upper limb module for spinal muscular atrophy: Development of a new module.

Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Young SD, Salazar R, De Sanctis R, Pasternak A, Glanzman A, Coratti G, Civitello M, Forcina N, Gee R, Duong T, Pane M, Scoto M, Pera MC, Messina S, Tennekoon G, Day JW, Darras BT, De Vivo DC, Finkel R, Muntoni F, Mercuri E.

Muscle Nerve. 2017 Jun;55(6):869-874. doi: 10.1002/mus.25430. Epub 2017 Feb 6.

PMID:
27701745
49.

Translational research in neuroendocrine tumors: pitfalls and opportunities.

Capdevila J, Casanovas O, Salazar R, Castellano D, Segura A, Fuster P, Aller J, García-Carbonero R, Jimenez-Fonseca P, Grande E, Castaño JP.

Oncogene. 2017 Apr 6;36(14):1899-1907. doi: 10.1038/onc.2016.316. Epub 2016 Sep 19. Review.

PMID:
27641330
50.

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.

Queralt B, Cuyàs E, Bosch-Barrera J, Massaguer A, de Llorens R, Martin-Castillo B, Brunet J, Salazar R, Menendez JA.

Oncotarget. 2016 Dec 13;7(50):82185-82199. doi: 10.18632/oncotarget.11985.

Supplemental Content

Loading ...
Support Center